Detecting and targeting neurodegenerative disorders using electrospun nanofibrous matrices: Current status and applications
YazarSiafaka, Panoraia I.
Özcan Bülbül, Ece
Karantas, Ioannis D.
Okur, Mehmet Evren
Üstündağ Okur, Neslihan
Üst veriTüm öğe kaydını göster
KünyeSiafaka, P. I., Özcan Bülbül, E., Dilsiz, P., Karantas, I. D., Okur, M. E. ve Üstündağ Okur, N. (2021). Detecting and targeting neurodegenerative disorders using electrospun nanofibrous matrices: Current status and applications. Journal of Drug Targeting, 29(5), 476-490. https://dx.doi.org/10.1080/1061186X.2020.1859516
Neurodegeneration is defined as the progressive atrophy and loss of function of neurons; it is present in neurodegenerative disorders such as Multiple Sclerosis, Alzheimer's, Huntington's, and Parkinson's diseases. The detection of such disorders is performed by various imaging modalities while their therapeutic management is quite challenging. Besides, the pathogenesis of neurodegenerative disorders is still under ongoing research due to complex and multi-factorial mechanisms. Currently, targeting the specific proteins responsible for neurodegeneration is of great interest to many researchers. Furthermore, nanotechnology-based approaches for targeting the affected neurons became an emerging field of interest. Nanostructures of various forms have been developed aiming to act as therapeutics for neurodegeneration, in which electrospun nanofibers seem to play an important role as biomedical products for both detection and management of the diseases. Electrospinning is an intriguing method able to produce nanofibers with a wide range of sizes and morphological characteristics. Such nanofibrous matrices can be delivered through different administration routes to target various diseases. In this review, the most recent advancements in electrospun nanofibrous systems that target or detect multiple neurodegenerative diseases have been enlightened and an introduction to the general aspects of neurodegenerative diseases and the electrospinning process has been made. Finally, future perspectives of neurodegeneration targeting were also discussed.